MedTrace Logo

Esophageal Hypersensitivity Study in Healthy Volunteers

NCT00711048 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2009-08-28

No results posted yet for this study

Summary

The purpose of the study is to compare sensitivity and sensitization of visceral pain in the esophagus using different pain stimuli

Conditions

  • Pain
  • Esophageal Sensitivity

Interventions

DRUG

AZD1386

oral, single dose

DRUG

Placebo

Oral solution, single dose

Sponsors & Collaborators

Principal Investigators

  • Marie Sundin · AstraZeneca R&D, Mölndal, Sweden

  • Peter Funch-Jensen, MD, PhD · Aarhus University Hospital, Dept of Surgical Gastroenterology, Aarhus, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Completion
2009-07-31

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711048 on ClinicalTrials.gov